Clinical Trial Update: Lovaza® and Microvascular Function in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of Lovaza (omega-3-acid ethyl esters) assessing microvascular function in adults with type 2 diabetes and hypertriglyceridemia or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Hypertriglyceridemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Hypertriglyceridemia, Diabetic Neuropathy | Phase 4 | Status: COMPLETED | Results posted: 2017-05-09